BRPI0715580A2
Antibodies to lymphotoxin-alpha
Abstract
The invention provides various antibodies that bind to lymphotoxin-α, methods for making such antibodies, compositions and articles incorporating such antibodies, and their uses in treating, for example, an autoimmune disorder. The antibodies include murine, chimeric, and humanized antibodies.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
33 members in 21 offices
Priority claims14
| Document | Office | Kind | Date |
|---|---|---|---|
| 60829257 | United States of America | – | |
| 82925706 | United States of America | P | |
| 82925706 | United States of America | P | |
| 60938999 | United States of America | – | |
| 93899907 | United States of America | P | |
| 93899907 | United States of America | P | |
| 2007081154 | United States of America | W | |
| 2007081154 | United States of America | W | |
| 2007081154 | – | – | – |
| 60829257 | – | – | – |
| 60938999 | – | – | – |
| US20060829257P | – | – | – |
| US20070938999P | – | – | – |
| WO2007US81154 | – | – | – |
Members33
| Document | Office | Kind | |
|---|---|---|---|
| AU2007324135A1 | Australia | A1 | |
| CA2665644A1 | Canada | A1 | |
| WO2008063776A2 | World Intellectual Property Organization (WIPO) | A2 | |
| TW200825101A | Taiwan Province of China | A | |
| AR063257A1 | Argentina | A1 | |
| WO2008063776A3 | World Intellectual Property Organization (WIPO) | A3 | |
| MX2009003774A | Mexico | A | |
| CR10705A | Costa Rica | A | |
| NO20091841L | Norway | L | |
| KR20090078349A | Republic of Korea | A | |
| EP2084188A2 | European Patent Office (EPO) | A2 | |
| MA30876B1 | Morocco | B1 | |
| CN101573380A | China | A | |
| US2009285830A1 | United States of America | A1 | |
| JP2010506568A | Japan | A | |
| ZA200902346B | South Africa | B | |
| CO6220841A2 | Colombia | A2 | |
| RU2009117680A | Russian Federation | A | |
| US7923011B2 | United States of America | B2 | |
| UA94484C2 | Ukraine | C2 | |
| US2011150865A1 | United States of America | A1 | |
| IL197937A0 | Israel | A0 | |
| US2011208673A1 | United States of America | A1 | |
| NZ576032A | New Zealand | A | |
| US8216807B2 | United States of America | B2 | |
| US2013011412A1 | United States of America | A1 | |
| AU2007324135B2 | Australia | B2 | |
| RU2486201C2 | Russian Federation | C2 | |
| US8541552B2 | United States of America | B2 | |
| JP5298021B2 | Japan | B2 | |
| TWI414531B | Taiwan Province of China | B | |
| US8642740B2 | United States of America | B2 | |
| BRPI0715580A2This record | Brazil | A2 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]LapsedEM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2327 DE 11-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.B08K | B08K | |
| Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]REFERENTE A 8A ANUIDADE.B08F | B08F |
Numbers
- Publication
- PI0715580
- Publication, DOCDB
- PI0715580
- Publication, EPODOC
- BRPI0715580
- Application
- 15580
- Application, DOCDB
- PI0715580
- Application, EPODOC
- BR2007PI15580
Titles2
- Portuguese
- ''ANTICORPO ANTI-LINFOTOXINA-a (LTa) ISOLADO, ANTICORPO HUMANIZADO, ANTICORPOS ANTI-LINFOTOXINA-a,COMPOSIÇÃO DE ANTICORPO,ANTICORPO ANTI-IDIOTIPO,HIBRIDOMA,ANTICORPO,ÁCIDO NUCLÉICO ISOLADO, VETOR DE EXPRESSÃO,CÉLULA HOSPEDEIRA,MÉTODO DE PRODUÇÃO DE UM ANTICORPO,MÉTODO PARA INIBIR A PROLIFERAÇÃO CELULAR ATIVADA POR LTa, MÉTODO PARA TRATAR UM DISTURBIO AUTO-IMUNE, ARTIGOS MANUFATURADOS, MÉTODO PARA DIVULGAR UM ANTICORPO E MÉTODO PARA EMBALAR O ANTICORPO''
- English
- 'ANTI-LYMPHOTOXIN-a (LTa) ANTIBODY, HUMANIZED ANTIBODY, ANTI-LYMPHOTOXIN-A ANTIBODIES, ANTIBODY COMPOSITION, ANTI-IDIOTITY ANTIBODY, HIBRIDOMA, ANTIBODY, ISOLATED NUCLEIC ACID, EXPRESSION VECTOR, HOST CELL, METHOD OF PRODUCTION OF AN ANTIBODY, METHOD FOR INHIBITING LT-ACTIVATED CELLULAR PROLIFERATION, METHOD FOR TREATING AN AUTO-IMMUNE DISTURB, MANUFACTURED ARTICLES, METHOD FOR DISCLOSING AN ANTIBODY AND METHOD FOR PACKAGING THE ANTIBODY ''
Classification
- CPC, 31
- C07K16/242
- C07K16/24
- A61K2039/505
- A61P1/00
- C07K2317/24
- A61P1/04
- C07K2317/41
- A61P1/16
- C07K2317/565
- A61P3/10
- C07K2317/567
- A61P5/14
- C07K2317/732
- A61P7/04
- C07K2317/76
- A61P13/12
- C07K2317/92
- A61P17/06
- G06Q99/00
- A61P19/02
- A61P21/00
- A61P21/04
- A61P25/00
- A61P29/00
- A61P31/04
- A61P31/12
- A61P31/14
- A61P37/00
- A61P37/02
- A61P37/06
- A61K39/395
- IPC, 4
- C07K16 24
- A61K39 395
- A61P37 06
- C07K14 525